Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response
Zhiyong Ma, Ejuan Zhang, Gao Shicheng, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
Zhongji Meng, Yuanyuan Chen, Mengji Lu
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 91
Hepatitis B functional cure and immune response
Jia-Rui Zheng, Zilong Wang, Bo Feng
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Innate and adaptive immune escape mechanisms of hepatitis B virus
Huajun Zhao, Yifei Hu, Qiuju Han, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 9, pp. 881-896
Open Access | Times Cited: 28
A Multivalent mRNA Therapeutic Vaccine Exhibits Breakthroughs in Immune Tolerance and Virological Suppression of HBV by Stably Presenting the Pre-S Antigen on the Cell Membrane
Shang Liu, Jie Wang, Yunxuan Li, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 211-211
Open Access
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo
Elena M. Smekalova, María Guadalupe Martínez, Emmanuel Combe, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 35, Iss. 1, pp. 102112-102112
Open Access | Times Cited: 12
Inhibition of Hepatitis B Virus Replication by a Novel GalNAc–siRNA In Vivo and In Vitro
Zhipeng Zhang, Yanqin Ma, Yan He, et al.
ACS Omega (2025) Vol. 10, Iss. 1, pp. 484-497
Open Access
The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
Ling Ding, Jiaquan Huang, Shuai-Wen Huang
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking
Lin Han, Xiu-Xiu Wei, Yu-Jiao Zheng, et al.
Chinese Medicine (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 32
The Role of B Cells in Adult and Paediatric Liver Injury
Arzoo Patel, Yuxin S. Liu, Scott Davies, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Contribution of T- and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases
Ejuan Zhang, Zhiyong Ma, Mengji Lu
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 15
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Sarah Kadelka, Harel Dahari, Stanca M. Ciupe
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
Arvin Medhat, Alla Arzumanyan, Mark A. Feitelson
Oncotarget (2021) Vol. 12, Iss. 24, pp. 2421-2433
Open Access | Times Cited: 19
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Jau-Hau Horng, Wei-Hsiang Lin, Chang-Ru Wu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 20
Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus
Daniel Sausen, Oren Shechter, William Bietsch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15973-15973
Open Access | Times Cited: 11
Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro
Taizo Mori, Sachiyo Yoshio, Shiori Yoshikawa, et al.
Liver International (2023) Vol. 43, Iss. 6, pp. 1213-1224
Closed Access | Times Cited: 6
Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
David C. Whitacre, CJ Peters, Camille Sureau, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 2, pp. 251-268
Open Access | Times Cited: 17
Hepatitis B virus particles activate B cells through the TLR2–MyD88–mTOR axis
Qian Li, Jun Wang, Heba Islam, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 13
IL-10 + CD19 + regulatory B cells induce CD4 + Foxp3 + regulatory T cells in serum of cervical cancer patients
Chunfeng Yang, Yuanyuan Zhang, Rui Wang, et al.
Autoimmunity (2023) Vol. 57, Iss. 1
Open Access | Times Cited: 4
The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming
Zhengmin Wang, Nan Liu, Yang Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Integrated analyses reveal CST7 and DUSP5 regulate Th2 cells differentiation to promote chronic HBV infection
Gang Ning, Xianxiang Liao, Hongye Jiang
Genes and Immunity (2024) Vol. 25, Iss. 5, pp. 423-433
Closed Access | Times Cited: 1
Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile
Sheng‐Jie Shiue, Chao-Ling Cheng, Han-Shiang Shiue, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2790-2790
Open Access | Times Cited: 7
Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling
Yan Chen, Biao Wang, Xiaowei Ou, et al.
Journal of Virology (2022) Vol. 96, Iss. 23
Open Access | Times Cited: 7
Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
Ning Li, Kangkang Yu, Minhui Dong, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1876-1889
Open Access | Times Cited: 6
Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review
Jieli Hu, Ailong Huang
Microorganisms (2023) Vol. 11, Iss. 3, pp. 600-600
Open Access | Times Cited: 3
A road to contemporary era of hepatitis B virus regimen replacing existing therapeutics exploiting plant secondary metabolites as emerging heroes in exploring drugs: An expedition for a functional cure
Sajad Ahmad Bhat, Syed Naqui Kazim
Gene Reports (2023) Vol. 30, pp. 101743-101743
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top